<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02017210</url>
  </required_header>
  <id_info>
    <org_study_id>ISOS (SVH 13/143)</org_study_id>
    <nct_id>NCT02017210</nct_id>
  </id_info>
  <brief_title>Insulin-sensitive Obesity: Lessons From Longitudinal Data</brief_title>
  <acronym>ISOS</acronym>
  <official_title>Insulin-sensitive Obesity: Prospective and Interventional Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Garvan Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Diabetes Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of New South Wales</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sydney</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St Vincent's Hospital, Sydney</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Garvan Institute of Medical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      People who are overweight and/or obese are at risk of insulin resistance and type 2 diabetes.
      However, research has shown that some overweight and/or obese individuals remain
      insulin-sensitive and metabolically healthy despite their unhealthy body weight.

      The investigators hypothesise that overweight and/or obese people who were deemed
      insulin-sensitive in previous studies will maintain their insulin sensitivity and metabolic
      health over time. The investigators also hypothesise that the preservation of insulin
      sensitivity will be accompanied by key metabolic health markers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      While obesity is a risk factor for metabolic disease, sub cohorts with obesity not
      complicated by the metabolic syndrome have been described. These so called &quot;metabolically
      healthy obese&quot; may have reduced risk of type 2 diabetes, cardiovascular disease and all-cause
      mortality compared with individuals with obesity who present with components of the metabolic
      syndrome.

      Longitudinal studies with diabetes and cardiovascular disease risk endpoints reported that
      individuals with obesity who are metabolically healthy (MHO) held an intermediate health
      status, such that they were still worse off than the healthy normal-weight individuals. While
      there have been studies evaluating the stability of the MHO phenotype over time, no study has
      reported the durability of insulin-sensitivity per se, as measured by the gold-standard
      hyperinsulinaemic-euglycaemic clamp. In the present study, we aimed to trace the change in
      insulin resistance/sensitivity, and to uncover predictors of insulin resistance in older age.
      The secondary aims were to trace the change in body composition, fat distribution and
      metabolic markers over time in a well-phenotyped cohort studied approximately 5-6 years
      apart.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Sensitivity</measure>
    <time_frame>6 years</time_frame>
    <description>The change in insulin sensitivity (as measured by M-value normalised to insulin from hyperinsulinemic-euglycemic clamp) was determined &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>6 years</time_frame>
    <description>Change in body mass index (BMI) was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist Circumference</measure>
    <time_frame>6 years</time_frame>
    <description>Change in waist circumference was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Fat Mass</measure>
    <time_frame>6 years</time_frame>
    <description>Body fat mass from dual-energy X-ray absorptiometry (DXA) change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body FFM</measure>
    <time_frame>6 years</time_frame>
    <description>Body fat-free mass (FFM) from DXA change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visceral Fat Volume</measure>
    <time_frame>6 years</time_frame>
    <description>Abdominal visceral fat volume from DXA change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>6 years</time_frame>
    <description>Change in Systolic Blood Pressure was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>6 years</time_frame>
    <description>Change in Diastolic Blood Pressure was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting Blood Glucose</measure>
    <time_frame>6 years</time_frame>
    <description>Change in fasting blood glucose was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting Serum Insulin</measure>
    <time_frame>6 years</time_frame>
    <description>Change in fasting serum insulin was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Insulin Sensitivity/Resistance</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Lean/normal weight</arm_group_label>
    <description>Individuals with body mass index (BMI)&lt;25 kg/m^2 in the baseline study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overweight/Obese Insulin-Sensitive</arm_group_label>
    <description>Individuals with BMI&gt;25kg/m^2 who were deemed insulin-sensitive by the hyperinsulinemic -euglycemic clamp (with M/I value above median for men and women separately)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overweight/Obese Insulin-Resistant</arm_group_label>
    <description>Individuals with BMI&gt;25kg/m^2 who were deemed insulin-resistant by the hyperinsulinemic -euglycemic clamp (with M/I value under median for men and women separately)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma, subcutaneous abdominal fat, skeletal muscle
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants of two previous separate studies performed at the Garvan Institute of Medical
        Research (Sydney, Australia) were contacted by postal mail to gauge interest in
        participating in this follow-up study. In the original studies, exclusion criteria included
        weight change greater than 2 kg in the preceding 6 months, self-reported regular exercise
        for periods longer than 60 min/week, treatment with medications known to affect insulin
        sensitivity or carbohydrate metabolism, known renal, cardiac, or liver disease and current
        cancer, planning pregnancy, consumption of more than 20 and 40 g/day alcohol for women and
        men, respectively, and smoking &gt;10 cigarettes/day
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participation in two previous studies conducted at the Garvan Institute of Medical
             Research Clinical Research Facility (described in the other publications 1-3).

          -  Willingness to give written informed consent and willingness to participate in the
             study.

        Exclusion Criteria:

          -  Pregnant and/or lactating women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>26 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry R Greenfield, MBBS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Garvan Institute of Medical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dorit Samocha-Bonet, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Garvan Institute of Medical Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dorit Samocha-Bonet</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <reference>
    <citation>Tonks KT, Ng Y, Miller S, Coster AC, Samocha-Bonet D, Iseli TJ, Xu A, Patrick E, Yang JY, Junutula JR, Modrusan Z, Kolumam G, St√∂ckli J, Chisholm DJ, James DE, Greenfield JR. Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects. Diabetologia. 2013 Apr;56(4):875-85. doi: 10.1007/s00125-012-2811-y. Epub 2013 Jan 24.</citation>
    <PMID>23344726</PMID>
  </reference>
  <reference>
    <citation>Heilbronn LK, Campbell LV, Xu A, Samocha-Bonet D. Metabolically protective cytokines adiponectin and fibroblast growth factor-21 are increased by acute overfeeding in healthy humans. PLoS One. 2013 Oct 18;8(10):e78864. doi: 10.1371/journal.pone.0078864. eCollection 2013.</citation>
    <PMID>24205333</PMID>
  </reference>
  <reference>
    <citation>Samocha-Bonet D, Campbell LV, Viardot A, Freund J, Tam CS, Greenfield JR, Heilbronn LK. A family history of type 2 diabetes increases risk factors associated with overfeeding. Diabetologia. 2010 Aug;53(8):1700-8. doi: 10.1007/s00125-010-1768-y. Epub 2010 May 12.</citation>
    <PMID>20461357</PMID>
  </reference>
  <results_reference>
    <citation>Tang A, Coster ACF, Tonks KT, Heilbronn LK, Pocock N, Purtell L, Govendir M, Blythe J, Zhang J, Xu A, Chisholm DJ, Johnson NA, Greenfield JR, Samocha-Bonet D. Longitudinal Changes in Insulin Resistance in Normal Weight, Overweight and Obese Individuals. J Clin Med. 2019 May 8;8(5). pii: E623. doi: 10.3390/jcm8050623.</citation>
    <PMID>31071971</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 9, 2013</study_first_submitted>
  <study_first_submitted_qc>December 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2013</study_first_posted>
  <results_first_submitted>January 14, 2020</results_first_submitted>
  <results_first_submitted_qc>February 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 24, 2020</results_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Garvan Institute of Medical Research</investigator_affiliation>
    <investigator_full_name>Dorit Samocha-Bonet</investigator_full_name>
    <investigator_title>Group leader Clinical Insulin Resistance Group</investigator_title>
  </responsible_party>
  <keyword>Hyperinsulinaemic-euglycaemic clamp</keyword>
  <keyword>Body fat composition</keyword>
  <keyword>Dual-energy x-ray absorptiometry</keyword>
  <keyword>Obesity</keyword>
  <keyword>Insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lean/Normal Weight</title>
          <description>Individuals with BMI &lt; 25 kg/m^2</description>
        </group>
        <group group_id="P2">
          <title>Overweight/Obese Insulin-Sensitive</title>
          <description>Individuals with BMI &gt; 25 kg/m^2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
        </group>
        <group group_id="P3">
          <title>Overweight/Obese Insulin-Resistant</title>
          <description>Individuals with BMI &gt; 25 kg/m^2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Lean/Normal Weight</title>
          <description>Individuals with body mass index (BMI)&lt;25 kg/m^2 in the baseline study</description>
        </group>
        <group group_id="B2">
          <title>Overweight/Obese Insulin-Sensitive</title>
          <description>Individuals with BMI&gt;25 kg/m^2 who were deemed insulin-sensitive at the baseline study</description>
        </group>
        <group group_id="B3">
          <title>Overweight/Obese Insulin-Resistant</title>
          <description>Individuals with BMI&gt;25 kg/m^2 who were deemed insulin-resistant at the baseline study</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="57"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.6" spread="11.1"/>
                    <measurement group_id="B2" value="54.2" spread="10.7"/>
                    <measurement group_id="B3" value="63.4" spread="10.7"/>
                    <measurement group_id="B4" value="57.5" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Insulin Sensitivity</title>
        <description>The change in insulin sensitivity (as measured by M-value normalised to insulin from hyperinsulinemic-euglycemic clamp) was determined &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>The hyperinsulinemic-euglycemic clamp was performed in a sub-cohort of n=9, 10 and 16 participants who were normal-weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant, respectively</population>
        <group_list>
          <group group_id="O1">
            <title>Lean/Normal Weight</title>
            <description>Individuals with BMI&lt;25 kg/m2 at the baseline study</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Individuals with BMI&gt;25 kg/m2 who were deemed insulin-sensitive at the baseline study</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Individuals with BMI&gt;25 kg/m2 who were deemed insulin-resistant at the baseline study</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Sensitivity</title>
          <description>The change in insulin sensitivity (as measured by M-value normalised to insulin from hyperinsulinemic-euglycemic clamp) was determined &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>The hyperinsulinemic-euglycemic clamp was performed in a sub-cohort of n=9, 10 and 16 participants who were normal-weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant, respectively</population>
          <units>micro mol/min/Kg/mU/L/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0105" lower_limit="-0.0202" upper_limit="0.0163"/>
                    <measurement group_id="O2" value="-0.0076" lower_limit="-0.0380" upper_limit="0.0073"/>
                    <measurement group_id="O3" value="0.0041" lower_limit="-0.0022" upper_limit="0.0109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Mass Index</title>
        <description>Change in body mass index (BMI) was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>All individuals who were followed up after 6 years were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Lean/Normal Weight</title>
            <description>Individuals with BMI&lt;25 kg/m2 at the baseline study</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Individuals with BMI&gt;25 kg/m2 who were deemed insulin-sensitive at the baseline study</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Individuals with BMI&gt;25 kg/m2 who were deemed insulin-resistant at the baseline study</description>
          </group>
        </group_list>
        <measure>
          <title>Body Mass Index</title>
          <description>Change in body mass index (BMI) was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>All individuals who were followed up after 6 years were analyzed</population>
          <units>kg/m^2/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0526" lower_limit="-0.0179" upper_limit="0.2842"/>
                    <measurement group_id="O2" value="0.0941" lower_limit="-0.0762" upper_limit="0.3689"/>
                    <measurement group_id="O3" value="0.0088" lower_limit="-0.1867" upper_limit="0.2309"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Waist Circumference</title>
        <description>Change in waist circumference was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>All individuals who were followed up after 6 years were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Lean/Normal Weight</title>
            <description>Individuals with BMI&lt;25 kg/m2 at the baseline study</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Individuals with BMI&gt;25 kg/m2 who were deemed insulin-sensitive at the baseline study</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Individuals with BMI&gt;25 kg/m2 who were deemed insulin-resistant at the baseline study</description>
          </group>
        </group_list>
        <measure>
          <title>Waist Circumference</title>
          <description>Change in waist circumference was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>All individuals who were followed up after 6 years were analyzed</population>
          <units>cm/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5263" lower_limit="-0.1924" upper_limit="1.2060"/>
                    <measurement group_id="O2" value="0.4894" lower_limit="-0.6522" upper_limit="1.1917"/>
                    <measurement group_id="O3" value="0.0000" lower_limit="-1.0812" upper_limit="0.6588"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Fat Mass</title>
        <description>Body fat mass from dual-energy X-ray absorptiometry (DXA) change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>DXA was performed in a sub-cohort of n=11, 11 and 19 in normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants, respectively</population>
        <group_list>
          <group group_id="O1">
            <title>Lean</title>
            <description>The Lean group included all individuals with BMI &lt; 25 kg/m2</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
          </group>
        </group_list>
        <measure>
          <title>Body Fat Mass</title>
          <description>Body fat mass from dual-energy X-ray absorptiometry (DXA) change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>DXA was performed in a sub-cohort of n=11, 11 and 19 in normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants, respectively</population>
          <units>% of total body mass/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2281" lower_limit="-0.2256" upper_limit="0.8134"/>
                    <measurement group_id="O2" value="0.3696" lower_limit="0.1465" upper_limit="0.5812"/>
                    <measurement group_id="O3" value="0.3478" lower_limit="-0.0303" upper_limit="0.5745"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body FFM</title>
        <description>Body fat-free mass (FFM) from DXA change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>DXA was performed in a sub-cohort of n=11, 11 and 19 in normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants, respectively</population>
        <group_list>
          <group group_id="O1">
            <title>Lean</title>
            <description>The Lean group included all individuals with BMI &lt; 25 kg/m2</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
          </group>
        </group_list>
        <measure>
          <title>Body FFM</title>
          <description>Body fat-free mass (FFM) from DXA change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>DXA was performed in a sub-cohort of n=11, 11 and 19 in normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants, respectively</population>
          <units>kg/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0382" lower_limit="-0.2930" upper_limit="0.0771"/>
                    <measurement group_id="O2" value="-0.1786" lower_limit="-0.3613" upper_limit="0.0333"/>
                    <measurement group_id="O3" value="-0.4017" lower_limit="-0.7577" upper_limit="0.0277"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visceral Fat Volume</title>
        <description>Abdominal visceral fat volume from DXA change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>Visceral fat volume was available in n=11, 10 and 18 normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants who undergone a DXA measure due to technical reasons</population>
        <group_list>
          <group group_id="O1">
            <title>Lean</title>
            <description>The Lean group included all individuals with BMI &lt; 25 kg/m2</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
          </group>
        </group_list>
        <measure>
          <title>Visceral Fat Volume</title>
          <description>Abdominal visceral fat volume from DXA change was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>Visceral fat volume was available in n=11, 10 and 18 normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants who undergone a DXA measure due to technical reasons</population>
          <units>cm^3/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.3962" lower_limit="-2.3225" upper_limit="75.3947"/>
                    <measurement group_id="O2" value="47.3351" lower_limit="-12.6000" upper_limit="94.9231"/>
                    <measurement group_id="O3" value="46.2974" lower_limit="27.1212" upper_limit="113.1915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic Blood Pressure</title>
        <description>Change in Systolic Blood Pressure was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>All individuals who were followed up after 6 years were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Lean</title>
            <description>The Lean group included all individuals with BMI &lt; 25 kg/m2</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure</title>
          <description>Change in Systolic Blood Pressure was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>All individuals who were followed up after 6 years were analyzed</population>
          <units>mmHg/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3704" lower_limit="-0.3548" upper_limit="2.8373"/>
                    <measurement group_id="O2" value="0.9483" lower_limit="-1.2137" upper_limit="2.5466"/>
                    <measurement group_id="O3" value="1.3593" lower_limit="-0.1087" upper_limit="4.1122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diastolic Blood Pressure</title>
        <description>Change in Diastolic Blood Pressure was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>All individuals who were followed up after 6 years were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Lean</title>
            <description>The Lean group included all individuals with BMI &lt; 25 kg/m2</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
          </group>
        </group_list>
        <measure>
          <title>Diastolic Blood Pressure</title>
          <description>Change in Diastolic Blood Pressure was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>All individuals who were followed up after 6 years were analyzed</population>
          <units>mmHg/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1290" lower_limit="-0.3792" upper_limit="2.8535"/>
                    <measurement group_id="O2" value="0.4117" lower_limit="-0.1567" upper_limit="1.3193"/>
                    <measurement group_id="O3" value="0.5662" lower_limit="-0.3191" upper_limit="1.9224"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fasting Blood Glucose</title>
        <description>Change in fasting blood glucose was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>Fasting blood glucose concentration measure was available in a sub-cohort of n=16, 18 and 19 in normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants, respectively</population>
        <group_list>
          <group group_id="O1">
            <title>Lean</title>
            <description>The Lean group included all individuals with BMI &lt; 25 kg/m2</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
          </group>
        </group_list>
        <measure>
          <title>Fasting Blood Glucose</title>
          <description>Change in fasting blood glucose was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>Fasting blood glucose concentration measure was available in a sub-cohort of n=16, 18 and 19 in normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants, respectively</population>
          <units>mmol/L/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0151" lower_limit="-0.0429" upper_limit="0.0500"/>
                    <measurement group_id="O2" value="0.0062" lower_limit="-0.0333" upper_limit="0.0373"/>
                    <measurement group_id="O3" value="-0.0254" lower_limit="-0.0962" upper_limit="0.0512"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fasting Serum Insulin</title>
        <description>Change in fasting serum insulin was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
        <time_frame>6 years</time_frame>
        <population>Fasting serum insulin measurement was available in a sub-cohort of n=16, 18 and 19 in normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants, respectively</population>
        <group_list>
          <group group_id="O1">
            <title>Lean</title>
            <description>The Lean group included all individuals with BMI &lt; 25 kg/m2</description>
          </group>
          <group group_id="O2">
            <title>Overweight/Obese Insulin-Sensitive</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
          </group>
          <group group_id="O3">
            <title>Overweight/Obese Insulin-Resistant</title>
            <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
          </group>
        </group_list>
        <measure>
          <title>Fasting Serum Insulin</title>
          <description>Change in fasting serum insulin was determined as &quot;Follow-up Value - Baseline Value&quot; /&quot;Time between measurements&quot;. There were 2 time points 6 years apart</description>
          <population>Fasting serum insulin measurement was available in a sub-cohort of n=16, 18 and 19 in normal weight, overweight/obese insulin-sensitive and overweight/obese insulin-resistant participants, respectively</population>
          <units>mU/L/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2223" lower_limit="-0.7104" upper_limit="1.2940"/>
                    <measurement group_id="O2" value="0.0855" lower_limit="-0.6545" upper_limit="0.4863"/>
                    <measurement group_id="O3" value="-0.2370" lower_limit="-1.8802" upper_limit="0.5054"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Serious and other [non-serious] adverse events were not collected or assessed as part of the study (observational study, no intervention administered)</time_frame>
      <desc>Not applicable (see above)</desc>
      <group_list>
        <group group_id="E1">
          <title>Lean/Normal Weight</title>
          <description>Individuals with BMI &lt; 25 kg/m2</description>
        </group>
        <group group_id="E2">
          <title>Overweight/Obese Insulin-Sensitive</title>
          <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Sensitive if their M/I value was above the median M/I value for each gender</description>
        </group>
        <group group_id="E3">
          <title>Overweight/Obese Insulin-Resistant</title>
          <description>Those with BMI &gt; 25 kg/m2 were categorised as Overweight/Obese Insulin-Resistant if their M/I were below the median M/I value for each gender</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study is limited by the small sample size, and the potential bias relating to populations likely to volunteer to studies which may have affected the findings. Furthermore, some data were missing for some individuals.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Dorit Samocha-Bonet</name_or_title>
      <organization>Garvan Institute of Medical Research</organization>
      <phone>+61292958309</phone>
      <email>d.samochabonet@garvan.org.au</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

